| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |